Published in Eur J Biochem on March 01, 1997
Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc Natl Acad Sci U S A (2002) 2.24
Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol Cell (2004) 2.02
Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. J Cell Biol (1999) 1.44
Proteases of malaria parasites: new targets for chemotherapy. Emerg Infect Dis (1998) 1.29
Antimalarial synergy of cysteine and aspartic protease inhibitors. Antimicrob Agents Chemother (1998) 1.27
Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols. Antimicrob Agents Chemother (1998) 1.26
Heme binding contributes to antimalarial activity of bis-quaternary ammoniums. Antimicrob Agents Chemother (2003) 1.17
New class of small nonpeptidyl compounds blocks Plasmodium falciparum development in vitro by inhibiting plasmepsins. Antimicrob Agents Chemother (2001) 1.02
Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors. Antimicrob Agents Chemother (2009) 0.98
Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis. Biochemistry (2009) 0.88
Structural aspects of activation pathways of aspartic protease zymogens and viral 3C protease precursors. Proc Natl Acad Sci U S A (1999) 0.87
Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin. Bioorg Med Chem (2008) 0.84
Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum. J Struct Biol (2011) 0.82
Structural studies of vacuolar plasmepsins. Biochim Biophys Acta (2011) 0.81
Inhibitory effects of pepstatin A and mefloquine on the growth of Babesia parasites. Am J Trop Med Hyg (2012) 0.81
Structural insights into the activation and inhibition of histo-aspartic protease from Plasmodium falciparum. Biochemistry (2011) 0.77
Molecular and biochemical characterization of hemoglobinase, a cysteine proteinase, in Paragonimus westermani. Korean J Parasitol (2006) 0.77
Disulfide linkages in Plasmodium falciparum plasmepsin-i are essential elements for its processing activity and multi-milligram recombinant production yield. PLoS One (2014) 0.76
Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design. J Trop Med (2011) 0.76
Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei. PLoS One (2015) 0.75
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell (1993) 5.37
Influence of tobacco marketing and exposure to smokers on adolescent susceptibility to smoking. J Natl Cancer Inst (1995) 4.61
Rational design of peptide-based HIV proteinase inhibitors. Science (1990) 4.57
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med (1996) 3.82
Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci U S A (1990) 3.59
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem (2000) 3.46
The fate of integrated treatment: whatever happened to the biopsychosocial psychiatrist? Am J Psychiatry (2001) 3.41
A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature (1989) 3.33
Bacterial transcript imaging by hybridization of total RNA to oligonucleotide arrays. Nat Biotechnol (1998) 3.29
An economic appraisal of alternative pre-natal screening programmes for Down's syndrome. J Public Health Med (1993) 2.92
Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71
Activation of CD4 cells by fibronectin and anti-CD3 antibody. A synergistic effect mediated by the VLA-5 fibronectin receptor complex. J Exp Med (1989) 2.69
Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med (1993) 2.67
Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA. Nat Nanotechnol (2006) 2.53
Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol (1993) 2.38
Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature (1995) 2.30
Addiction versus stages of change models in predicting smoking cessation. Addiction (1996) 2.29
Bacillus sphaericus strain 2362: identification and nucleotide sequence of the 41.9 kDa toxin gene. Nucleic Acids Res (1987) 2.24
Identification, cloning and sequence analysis of the Bacillus sphaericus 1593 41.9 kD larvicidal toxin gene. Mol Microbiol (1987) 2.21
The development of a tool to assess neonatal pain. Neonatal Netw (1993) 2.08
Access to hematin: the basis of chloroquine resistance. Mol Pharmacol (1998) 2.03
Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor. J Exp Med (1990) 2.02
Subregions of a conserved part of the HIV gp41 transmembrane protein are differentially recognized by antibodies of infected individuals. EMBO J (1986) 2.01
"No fixed abode": a survey of mental hospital admissions. Br J Psychiatry (1966) 1.96
Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis (1995) 1.96
Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria. Dev Med Child Neurol (1992) 1.94
Functional outcomes of pediatric liver transplantation. J Pediatr Gastroenterol Nutr (2003) 1.93
Human TNF mutants with selective activity on the p55 receptor. Nature (1993) 1.91
Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol (2001) 1.90
An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem Pharmacol (1998) 1.90
Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures. J Immunol (1987) 1.89
Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet (1992) 1.88
Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci U S A (2001) 1.87
Growth in utero, adult blood pressure, and arterial compliance. Br Heart J (1995) 1.80
Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol (1991) 1.78
Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. Am J Obstet Gynecol (1990) 1.76
Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine (1990) 1.72
API Listeria, a new and promising one-day system to identify Listeria isolates. Appl Environ Microbiol (1992) 1.71
Sensitive, soluble chromogenic substrates for HIV-1 proteinase. J Biol Chem (1990) 1.70
Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. J Biol Chem (1990) 1.69
Polymorphism of the precursor for the major surface antigens of Plasmodium falciparum merozoites: studies at the genetic level. EMBO J (1985) 1.69
4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother (1996) 1.65
Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology (1992) 1.63
Complications associated with a narrow bore nasogastric tube. Ann Otol Rhinol Laryngol (1984) 1.62
Yeast may not contain histone H1: the only known 'histone H1-like' protein in Saccharomyces cerevisiae is a mitochondrial protein. Nucleic Acids Res (1984) 1.61
Traumatic deidealization and the future of medicine. JAMA (1990) 1.61
Continuing with pregnancy after a diagnosis of lethal abnormality: experience of five couples and recommendations for management. BMJ (1996) 1.60
Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect Immun (1991) 1.60
Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol (1997) 1.59
Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J Pediatr (1991) 1.59
The course of alcohol withdrawal in a general hospital. QJM (1997) 1.59
A naturally occurring gene encoding the major surface antigen precursor p190 of Plasmodium falciparum lacks tripeptide repeats. EMBO J (1987) 1.58
Prevalence of malnutrition on admission to four hospitals in England. The Malnutrition Prevalence Group. Clin Nutr (2000) 1.56
Bacillus sphaericus strain 2297: nucleotide sequence of 41.9 kDa toxin gene. Nucleic Acids Res (1988) 1.56
Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance. Biochemistry (1995) 1.56
Reducing tobacco consumption in California: Proposition 99 seems to work. JAMA (1991) 1.55
Cloning, sequencing, and expression of a gene encoding a 100-kilodalton mosquitocidal toxin from Bacillus sphaericus SSII-1. J Bacteriol (1991) 1.53
Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve (1989) 1.52
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51
Zymogens of proteolytic enzymes. Science (1973) 1.51
Impact of the American Stop Smoking Intervention Study on cigarette consumption. Tob Control (1997) 1.50
Hemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features. J Pediatr (1989) 1.50
Use of prior vaccinations for the development of new vaccines. Science (1990) 1.48
Recent advances in angiotensin II signaling. Braz J Med Biol Res (2002) 1.46
Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection. Infect Immun (1992) 1.45
Viral proteinases: weakness in strength. Biochim Biophys Acta (1990) 1.43
Saskatchewan. Campylobacter jejuni abortion in beef cattle. Can Vet J (1989) 1.43
A prospective survey of reactions to blood tests by children and adolescents. Pain (1990) 1.42
Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes. J Exp Med (1991) 1.40
Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J Exp Med (1990) 1.39
Incidence of antibiotic resistance in Listeria species. J Infect Dis (1995) 1.38
Preparation and Use of Dried Plasma for Transfusion. Br Med J (1940) 1.38
Listeriosis from consumption of raw-milk cheese. Lancet (1995) 1.37
A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur J Immunol (1990) 1.35
"Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart (2002) 1.35
The autoactivation of trypsinogen. J Biol Chem (1971) 1.35
Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3. Mol Biochem Parasitol (1997) 1.34
Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites. Biochemistry (1992) 1.33
Differences in duration of pregnancy. Negro and white women of low socioeconomic class. Arch Environ Health (1967) 1.32
Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J Immunol (1992) 1.32
Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat Biotechnol (1996) 1.32
Nonpolymorphic regions of p190, a protein of the Plasmodium falciparum erythrocytic stage, contain both T and B cell epitopes. J Immunol (1988) 1.31
Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol (1998) 1.29
A systematic series of synthetic chromophoric substrates for aspartic proteinases. Biochem J (1986) 1.28
Immunization of Aotus monkeys with Plasmodium falciparum blood-stage recombinant proteins. Proc Natl Acad Sci U S A (1990) 1.28
Prophylactic treatment of very premature infants with human surfactant. N Engl J Med (1986) 1.27
Summary of a novel, three-component regulatory model for uridine diphosphate glucuronyltransferase. Biochem Soc Trans (1976) 1.27
Surveillance of listeria infections in Europe. Euro Surveill (2005) 1.26
Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems. Health Technol Assess (2010) 1.26
Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols. Antimicrob Agents Chemother (1998) 1.26
Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol (1992) 1.25
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J Med Chem (2000) 1.25
In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants. Eur J Immunol (1993) 1.24
Epidemiology of human listeriosis and seafoods. Int J Food Microbiol (2000) 1.24